Management of Tricuspid Regurgitation in Patients with Rheumatic Mitral Disease
Optimal management of TR in rheumatic mitral disease requires individualized, Heart Team-based decision-making due to limited high-quality evidence. Future research should prioritize multicenter trials comparing repair, replacement, and transcatheter approaches, integrating advanced imaging for risk stratification and addressing access disparities in resource-limited settings.
Authors
- Shagun Gupta (ORCID: https://orcid.org/0000-0002-1981-8801)
- Mohammad El‐Diasty (ORCID: https://orcid.org/0000-0002-1807-8397)
- Zohair Al‐Halees
- Rohan Kalasipudi
- Y. Abu-Omar
- A. Al-Akhtar
- A. Meghdadi
Institutions
- St. George's University (GD)
- University of Ottawa (CA)
- Qassim University (SA)
- Queen's University (CA)
- University Hospitals of Cleveland (US)
Publication Details
- Journal
- PubMed
- Published
- 2025-11-12
- DOI
- https://doi.org/10.48729/pjctvs.604
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00